Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ARL14 effector protein-like (ARL14EPL) is a protein-coding gene that encodes a protein of unknown function, with homology to ADP-ribosylation factor (ARF) family GTPase effector proteins. The official name is based on its annotated similarity to ARL14 effectors, but there is no strong experimental evidence establishing its molecular function or involvement in specific pathways or cellular processes in humans. The gene is expressed in various tissues, but subcellular and pathway annotations are predicted and not validated by protein-level experiments. Although genetic studies have associated its locus with Dystonia 11 and Familial Adenomatous Polyposis 1, these links are not fully understood and lack direct mechanistic confirmation. The paralog ARL14EP is also described but with similarly limited functional information. There is currently insufficient evidence to classify ARL14EPL as a therapeutic target or to assign it to a well-defined molecular family or disease mechanism.
None reported for drugs, as there are no known drug interactions or pharmacology
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ARL14 effector protein-like (ARL14EPL).